EFFICACY AND SAFETY OF REPEATED INTERMITTENT TREATMENT WITH ELTROMBOPAG IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

被引：0
|
作者：
Psaila, B. [1 ]
Bussel, J. [1 ]
Vasey, S. [2 ]
Aivado, M. [2 ]
Mayer, B. [2 ]
Stone, N. [2 ]
Arning, M. [2 ]
机构：
[1] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA
[2] GlaxoSmithKline, Collegeville, PA USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0294
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Repeated Intermittent Treatment with Eltrombopag in Patients with Chronic Idiopathic Thrombocytopenic Purpura
    Bussel, James B.
    Psaila, Bethan
    Saleh, Mansoor N.
    Vasey, Sandra
    Mayer, Bhabita
    Stone, Nicole L.
    Arning, Michael
    BLOOD, 2008, 112 (11) : 1176 - 1177
  • [2] LONG-TERM SAFETY AND EFFICACY OF ORAL ELTROMBOPAG FOR THE TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
    Bussel, J. B.
    Cheng, G.
    Saleh, M. N.
    Meddeb, B.
    Stone, N.
    Mayer, B.
    Arning, M.
    Aivado, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 379 - 379
  • [3] Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
    Bussel, James B.
    Cheng, Gregory
    Saleh, Mansoor N.
    Psaila, Bethan
    Kovaleva, Lidia
    Meddeb, Balkis
    Kloczko, Janusz
    Hassani, Habib
    Mayer, Bhabita
    Stone, Nicole L.
    Arning, Michael
    Provan, Drew
    Jenkins, Julian M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22): : 2237 - 2247
  • [4] Safety and Efficacy of Long-Term Treatment with Oral Eltrombopag for Chronic Idiopathic Thrombocytopenic Purpura
    Bussel, James B.
    Cheng, Gregory
    Saleh, Mansoor N.
    Meddeb, Balkis
    Bailey, Christine
    Stone, Nicole L.
    Aivado, Manuel
    BLOOD, 2008, 112 (11) : 1177 - 1177
  • [5] The treatment of chronic idiopathic thrombocytopenic purpura (ITP)
    Bakic, M
    Tasic, J
    Pavlovic, M
    MacukanovicGolubovic, L
    Draskovic, S
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1126 - P1126
  • [6] Eltrombopag for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura
    Dmytrijuk, Andrew
    Robie-Suh, Kathy
    Rieves, Dwaine
    Pazdur, Richard
    ONCOLOGY-NEW YORK, 2009, 23 (13): : 1171 - 1177
  • [7] Oral eltrombopag reduces the need for concomitant medications in patients with chronic idiopathic thrombocytopenic purpura (ITP)
    Fogarty, P.
    Bussel, J. B.
    Cheng, G.
    Saleh, M. N.
    Meddeb, B.
    Bailey, C.
    Brainsky, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 30 - 30
  • [8] Eltrombopag in chronic idiopathic thrombocytopenic purpura
    Panzer, Simon
    Pabinger, Ingrid
    LANCET, 2009, 373 (9664): : 607 - 608
  • [9] Eltrombopag for the treatment of idiopathic thrombocytopenic purpura
    Stasi, Roberto
    EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (02) : 145 - 152
  • [10] THE EFFICACY OF REVOLADE(ELTROMBOPAG) IN IDIOPATHIC AUTOIMMUNE THROMBOCYTOPENIC PURPURA(ITP)-SINGLE CENTER EXPERIENCE
    Mihaescu, R.
    Borzak, G.
    Stoian, A.
    Buzas, R.
    HAEMATOLOGICA, 2013, 98 : 742 - 742
12345